Perioperative coagulation management in a patient with afibrinogenemia undergoing liver transplantation

Liver Transplantation

Volumn 13, Issue 5, 2007, Pages 752-756

  Fuchs, Ralph J ^a   Levin, Jay ^a   Tadel, Meghan ^a   Merritt, William ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; CALCIUM CHLORIDE; FIBRIN; FIBRINOGEN; THROMBIN;

ABDOMINAL WALL; ADULT; AFIBRINOGENEMIA; ARTICLE; ASCITES; BLOOD CLOTTING; BLOOD TRANSFUSION; BUDD CHIARI SYNDROME; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CRYOPRECIPITATE; FEMALE; FIBRINOGEN BLOOD LEVEL; FIBRINOGEN DEFECT; FIBRINOLYSIS; GENE MUTATION; HEPATOMEGALY; HISPANIC; HOSPITAL ADMISSION; HUMAN; HYPERKALEMIA; INTERNATIONAL NORMALIZED RATIO; LIVER TRANSPLANTATION; LIVER VEIN OBSTRUCTION; MUCOSAL BLEEDING; PERIOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SCORING SYSTEM; THROMBOELASTOGRAPHY; TREATMENT OUTCOME; UMBILICAL VEIN;

ADULT; AFIBRINOGENEMIA; BLOOD COAGULATION; FEMALE; HEPATIC VEIN THROMBOSIS; HUMANS; LIVER TRANSPLANTATION; PERIOPERATIVE CARE; THROMBELASTOGRAPHY; TREATMENT OUTCOME;

EID: 34249049189     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21164     Document Type: Article

References (9)

1. Martinez J, Ferber A. Disorders of fibrinogen. In: Hoffman R, Benz EJ, Shatill SJ, eds. Hematology: Basic Principles and Practice. 4th ed. Philadelphia: Elsevier, Churchill, Livingstone; 2005:2098-2100.
2. Lisman T, Porte RJ, Leebeek FWG, Caldwell SH. Methodological issues with coagulation testing in patients with liver disease. J Thromb Haemost 2006;4:2061-2062.
3. Heuman DM, Mihas AA, Habib A, Gilles HS, Stravitz RT, Sanyal AJ, et al. MELD-XI: a rational approach to "sickest first" liver transplantation in cirrhotic patients requiring anticoagulant therapy. Liver Transpl 2007;13:30-37.
4. Oruc N, Tokat Y, Killi R, Tombuloglu M, Ilter T. Budd-Chiari syndrome in an afibrinogenemic patient: a paradoxical complication. Dig Dis Sci 2006;52:378-380.
5. Remijn JA, Wu JP, Ijsseldijk MJW, Zwaginga JJ, Sixma JJ, de Groot PG. Absence of fibrinogen in afibrinogenemia results in large but loosely packed thrombi under flow conditions. Thromb Haemost 2001;85:736-742.
6. Hanano M, Takahashi H, Itoh M, Shibata A. Coexistence of congenital afibrinogenemia and protein C deficiency in a patient. Am J Hematol 1992;41:57-60.
7. Kang YG, Martin DJ, Marquez J, Lewis JH, Bontempo FA, Shaw BW Jr, et al. Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg 1985;64:888-896.
8. Dupuy E, Soria C, Molho P, Zini J-M, Rosenstingl S, Laurian C, et al. Embolized ischemic lesions of toes in an afibrinogenemic patient: possible relevance to in vivo circulating thrombin. Thromb Res 2001;102:211-219.
9. de Bosch NB, Mosesson MW, Ruiz-Saez A, Echenagucia M, Rodriguez-Lemoin A. Inhibition of thrombin generation in plasma by fibrin formation (antithrombin I). Thromb Haemost 2002;88:253-258.